Abstract:OBJECTIVE:To investigate and analyze the differential prevalence, as well as the risk factors and clinical features, of occult hepatitis B virus (HBV) infection in the human immunodeficiency virus (HIV)-infected population without antiretroviral therapy (ART) as compared to the general (non-HIV-infected) population. METHODS:Two-hundred-and-forty-eight individuals with confirmed HIV infection but ART naive (males: 220, females: 28; 15-82 years old) were enrolled in the study, along with 121 healthy individuals (confirmed HIV antibody-negative; males: 53, females: 68; 20-88 years old). HBV markers (hepatitis B surface antigen (HBsAg); hepatitis B e antigen (HBeAg); anti-HBs, anti-HBe and anti-hepatitis B core (HBc) antibodies) were detected by microparticle enzyme-linked immunosorbent assay (AxSYM immunology analyzer manufactured by Abbott Laboratories); all cases and controls were confirmed negative for hepatitis B surface antigen (HBsAg). Then, the HBV DNA level in serum was detected using nucleic acid amplification assay (COBAS AmpliPrep/COBAS TaqMan HBV test, version 2.0 manufactured by Roche). CD4+ T lymphocytes were measured by flow cytometry, and alanine aminotransferase (ALT, marker of liver function) was measured by enzymatic assay. RESULTS:Twenty-four of the HIV cases (9.7%) and four of the healthy controls (3.3%) tested positive for HBV DNA; the amount of individuals with HBV DNA-positivity was significantly higher in the HIV-infected group (P = 0.035). Among the 24 cases of HBV DNA(+) HIV-infected individuals, the lowest HBV DNA load was < 20 IU/ml and the highest was 3.22 x 10s IU/ml; nine of the individuals (37.5%) had HBV DNA load > 100 IU/ml, four (16.7%) had 20-99 IU/ ml, and 11 (45.8%) had < 20 IU/ml. Among the total HIV-infected cases with HBV DNA-positivity, 7.3% (8/110) were anti-HBc(+)/anti-HBs(+), 20.8% (11/53) were anti-HBc(+)/anti-HBs(-), 14.3% (3/21) were anti-HBc(-)/anti-HBs(+), and 3.1% (2/64) were anti-HBc(-)/anti-HBs(-). The amount of individuals with HBV DNA-positivity in the anti-HBc(+)/anti-HBs(-) group was significantly different from those in the anti-HBc(+)/anti-HBs(+) group (P = 0.018) and the anti-HBc(-)/anti-HBs(-) group (P = 0.003). However, multiple comparison of HBV DNA loads detected between the four groups of HBV marker status revealed no significant difference (P = 0.805). Furthermore, statistical analysis provided no evidence to support that occult hepatitis B infection in HIV-infected individuals had any impact on CD4+ T lymphocytes count (Z = 1.902, P = 0.059) or ALT levels (Z =1.401, P = 0.161). CONCLUSION:HIV-infected individuals who are ART naive and HBsAg(-) have a higher incidence of HBV DNA-positivity than individuals in the general (non-HIV-infected) population. In addition, the highest rate of occult hepatitis B among the HIV-infected cases occurred among individuals who were anti-HBc(+)/anti-HBs(-).

Prevalence of occult hepatitis B virus infection in general adults

Retrospective Analysis of Hepatitis B Virus Serological Markers in 70 582 Inpatients

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Epidemiological analysis of serum HBV DNA level among 13 039 patients with Hepatitis B

Study on hepatitis B virus genotypes in Wenzhou district by PCR using type-specific primers and its clinical significance

Prevalence of Occult HBV Infection in Accepted Blood Donors

Serolological Profile among HBsAg-Positive Infections in Southeast China: A Community-Based Study

[A Cross-Sectional Survey of Occult Hepatitis B Virus Infection in HIV-infected Patients].

Hepatitis B Virus Genotypes, Phylogeny and Occult Infection in a Region with a High Incidence of Hepatocellular Carcinoma in China

Occult Hepatitis B: Immunohistochemistry Staining for HBV Antigens on Liver Biopsies and Sequence Analysis of HBV S Gene.

[Epidemiological and Clinical Features of Occult Hepatitis B in HIV Infection Without Antiretroviral Treatment].

Rare Detection of Occult Hepatitis B Virus Infection in Children of Mothers with Positive Hepatitis B Surface Antigen.

Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China

Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study.

Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based Study

Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection.

Occult Hepatitis B Virus Infection with Positive Hepatitis B E Antigen

Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors

Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or Without Hepatitis.

Prevalence and influential factors of isolated hepatitis B core antibody positivity in a Chinese adult population